About Clevergene
Clevergene is a company based in Bengaluru (India) founded in 2013 by Tony Jose. Clevergene has raised $632.77 thousand across 1 funding round from investors including Auxano and Ajay Kuamr. The company has 2 employees as of April 01, 2024. Clevergene offers products and services including Genome Sequencing, Epigenome Sequencing, Metagenome Sequencing, RNA Sequencing, and Single Cell Expression. Clevergene operates in a competitive market with competitors including Omniome, Novogene Corporation, Rejuvenate Bio, HitGen and Source BioScience, among others.
- Headquarter Bengaluru, India
- Employees 2 as on 01 Apr, 2024
- Founders Tony Jose
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Clevergene Biocorp Private Limited
- Date of Incorporation 04 Jun, 2013
- Jurisdiction Bengaluru, Karnataka, India
-
Annual Revenue
$1.21 M (USD)39.07as on Mar 31, 2022
-
Net Profit
-$210.32 K (USD)-349.24as on Mar 31, 2022
-
EBITDA
$146.67 K (USD)-28.98as on Mar 31, 2022
-
Total Equity Funding
$632.77 K (USD)
in 1 rounds
-
Latest Funding Round
$632.77 K (USD), Seed
Jan 20, 2020
-
Investors
Auxano
& 1 more
-
Employee Count
2
as on Apr 01, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clevergene
Clevergene offers a comprehensive portfolio of products and services, including Genome Sequencing, Epigenome Sequencing, Metagenome Sequencing, RNA Sequencing, and Single Cell Expression.
Service for assembling genomes and identifying genetic variants.
Analyzes epigenetic changes in biological samples.
Profiles microbial communities through genomic analysis.
Measures gene expression in various biological contexts.
Examines gene expression at the single-cell level.
Offers solutions for genetic ailment diagnostics.
Funding Insights of Clevergene
Clevergene has successfully raised a total of $632.77K through 1 strategic funding round. The most recent funding activity was a Seed round of $632.77 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Clevergene
Clevergene has secured backing from 2 investors, including venture fund and angel investors. Prominent investors backing the company include Auxano and Ajay Kuamr.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment funding and strategic guidance are provided by Auxano.
|
Locked | Locked | Locked | |
|
AK
Ajay Kuamr |
Angel investor, ex-entrepreneur, focused on Indian startups in tech and consumer sectors.
|
Locked | Locked | Locked |
Investor details for Clevergene
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clevergene
Investment portfolio details for Clevergene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Clevergene
Detailed financials for Clevergene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clevergene Comparisons
Peer comparison for Clevergene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Clevergene
Clevergene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Novogene Corporation, Rejuvenate Bio, HitGen and Source BioScience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
Detailed competitors of Clevergene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clevergene
Complete news archive for Clevergene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clevergene
Clevergene was founded in 2013 and raised its 1st funding round 7 years after it was founded.
Clevergene is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Tony Jose is the current CEO of Clevergene. They have also founded this company.
Clevergene is a funded company, having raised a total of $632.77K across 1 funding round to date.
As of Apr 01, 2024, the latest employee count at Clevergene is 2.
Annual revenue of Clevergene is $1.21M as on Mar 31, 2022.
Clevergene was founded in 2013 in Bengaluru, India, focusing on the bioinformatics sector. Genomic-based solutions are delivered for research and translational sciences through high-throughput DNA sequencing and big data analytics. Problems in these areas are addressed via services such as genome analysis, transcriptome analysis, SNP analysis, epigenome analysis, small RNA analysis, statistical modeling, metagenome analysis, CNV analysis, and microarray data analysis. Operations center on analytics and sequencing technologies.
Clevergene's top competitors include Novogene Corporation, Singular Genomics and Source BioScience.
Clevergene offers Genome Sequencing, Epigenome Sequencing, Metagenome Sequencing, RNA Sequencing, and 2 more products and services.
Clevergene has 2 investors. Key investors include Auxano, and Ajay Kuamr.
The valuation of Clevergene is $4.05M as of Jan 2020.